AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock

NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗

$12,08

Fiyat · May 20, 2026

Temel veriler itibarıyla May 7, 2026

52 Haftlık Aralık

$7–$15

62% of range

Analist Derecelendirmesi

AMRX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$12.08

Piyasa Değeri

—

P/E (TTM)

57.3

EPS (TTM)

$0.22

Gelir (TTM)

$3.02B

Temettü Verimi

—

ROE

-80.0%

D/E Borç/Özsermaye

-36.3

52 Haftlık Aralık

$7 – $15

AMRX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $3.02B

2016-12-31 → 2025-12-31

Hisse Başına Kâr $0.22

2018-12-31 → 2025-12-31

Serbest Nakit Akışı $270M

2018-12-31 → 2025-12-31

Marjlar 2.4%

2018-12-31 → 2025-12-31

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

AMRX

Akran Ortalaması

P/E (TTM)

57.3

42.1

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

AMRX

Akran Ortalaması

Gross Margin (Brüt Kar Marjı)

36.9%

86.3%

Operating Margin (Faaliyet Kâr Marjı)

13.1%

—

Net Profit Margin (Net Kâr Marjı)

2.4%

-3.7%

ROA

2.0%

-13.2%

ROE

-80.0%

-21.9%

ROIC

14.5%

—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

AMRX

Akran Ortalaması

Debt / Equity (Borç / Öz Sermaye)

-36.3

13657.6

Current Ratio (Cari Oran)

2.2

4.1

Quick Ratio (Cari Oran)

0.3

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

AMRX

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

8.1%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

10.9%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

8.7%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

AMRX

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$0.22

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

AMRX

Akran Ortalaması

AMRX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 11 analist

Güçlü Al 2 18,2%
Al 8 72,7%
Tut 1 9,1%
Sat 0 0,0%
Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

5 analist · 2026-05-16

Medyan $17.00

← Tüm hedeflerin altında $12.08

Düşük $15.00

Yüksek $19.00

Medyan hedef $17.00 +40,7%

Ortalama hedef $17.00 +40,7%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

0.06%

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
31 Mart 2026	$0.27	$0.17	0.10%
31 Aralık 2025	$0.21	$0.19	0.02%
30 Eylül 2025	$0.17	$0.14	0.03%
30 Haziran 2025	$0.25	$0.18	0.07%
31 Mart 2025	$0.21	$0.15	0.06%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
AMRX	—	57.3	8.1%	2.4%	-80.0%	36.9%
SUPN	$2.86B	-73.1	8.6%	-5.4%	-3.6%	—
ALMS	—	-3.4	—	-1011.8%	-61.9%	—
TARS	$3.48B	-51.5	146.7%	-14.7%	-19.7%	—
GPCR	$14.78B	-86.9	—	—	-12.3%	—
ELVN	$915M	-8.4	—	—	-21.9%	—
NKTR	$862M	-4.3	-43.9%	-297.1%	-500.1%	—
DFTX	$1.32B	-6.5	212.0%	—	-71.0%	—
PBH	$3.33B	15.2	-4.3%	17.5%	10.2%	54.7%
TRVI	$1.61B	-39.1	—	—	-22.4%	—

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 15

AMRX için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$3.02B	$2.79B	$2.39B	$2.21B	$2.09B	$1.99B	$1.63B	$1.66B	$1.03B
Cost of Revenue	$1.91B	$1.77B	$1.57B	$1.43B	$1.32B	$1.33B	$1.15B	$939M	$507M
Gross Profit	$1.11B	$1.02B	$821M	$785M	$769M	$628M	$353M	$716M	$526M
R&D Expense	$186M	$191M	$164M	$196M	$202M	$180M	$188M	$194M	$171M
SG&A Expense	$527M	$476M	$430M	$400M	$366M	$327M	$290M	$228M	$109M
Operating Income	$394M	$249M	$204M	$-95M	$153M	$91M	$-249M	$-20M	$245M
Other Non-op	$17M	$12M	$8M	$18M	$15M	$3M	$1M	$1M	$-47.0K
Pretax Income	$139M	$-55M	$-40M	$-248M	$31M	$-36M	$-220M	$-203M	$171M
Income Tax	$11M	$19M	$8M	$7M	$11M	$-104M	$383M	$-1M	$2M
Net Income	$72M	$-117M	$-84M	$-255M	$13M	$68M	$-604M	$-20M	$0
EPS (Basic)	$0.23	$-0.38	$-0.48	$-0.86	$0.07	$0.62	$-2.74	$-0.16	·
EPS (Diluted)	$0.22	$-0.38	$-0.48	$-0.86	$0.07	$0.61	$-2.74	$-0.16	·
Shares (Basic)	313,367,000	308,978,000	176,136,000	150,944,000	148,922,000	147,443,000	132,106,000	127,252,000	·
Shares (Diluted)	324,805,000	308,978,000	176,136,000	150,944,000	151,821,000	148,913,000	132,106,000	127,252,000	·
EBITDA	$394M	$249M	$204M	$-95M	$153M	$91M	$-249M	$-20M	·

Bilanço 27

AMRX için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$282M	$111M	$92M	$26M	$248M	$341M	$151M	$213M	$74M
Receivables	·	·	·	$742M	$663M	$639M	$604M	$481M	$351M
Inventory	$606M	$612M	$581M	$531M	$489M	$491M	$381M	$457M	$284M
Prepaid Expense	$98M	$81M	$83M	$104M	$110M	$73M	$70M	$128M	$42M
Current Assets	$1.91B	$1.59B	$1.38B	$1.41B	$1.52B	$1.55B	$1.21B	$1.29B	$772M
PP&E (Net)	$443M	$425M	$448M	$470M	$514M	$478M	$478M	$544M	$487M
PP&E (Gross)	$1.05B	$988M	$956M	$916M	$909M	$810M	$754M	$754M	$643M
Accum. Depreciation	$606M	$564M	$508M	$446M	$395M	$332M	$276M	$209M	$156M
Goodwill	$595M	$597M	$599M	$599M	$593M	$523M	$420M	$426M	$26M
Intangibles	$563M	$732M	$890M	$1.10B	$1.17B	$1.30B	$1.38B	$1.65B	$45M
Other Non-current Assets	$58M	$60M	$56M	$103M	$21M	$22M	$44M	$68M	$11M
Total Assets	$3.68B	$3.50B	$3.47B	$3.80B	$3.94B	$4.01B	$3.67B	$4.35B	$1.34B
Accounts Payable	·	$259M	$144M	$166M	$131M	$153M	$103M	$115M	$70M
Current Liabilities	$882M	$1.13B	$847M	$753M	$677M	$677M	$550M	$554M	$297M
Capital Leases	·	·	·	·	·	·	·	$39M	$40M
Deferred Tax	·	·	·	·	·	·	$0	$1M	$2M
Other Non-current Liabilities	·	·	·	$87M	$39M	$83M	$40M	$39M	$8M
Total Liabilities	·	·	·	·	·	·	·	·	$0
Long-term Debt	$2.57B	$2.39B	$2.42B	$2.62B	$2.71B	$2.78B	$2.63B	$2.65B	$1.44B
Total Debt	$2.57B	$2.39B	$2.42B	$2.62B	$2.71B	$2.78B	$2.63B	$2.65B	·
Common Stock	·	·	·	·	·	·	·	·	$10
Paid-in Capital	$572M	$560M	$539M	$692M	$658M	$628M	$607M	$530M	$9M
Retained Earnings	$-535M	$-607M	$-490M	$-406M	$-276M	$-287M	$-378M	$-21M	$-383M
AOCI	$-111M	$-66M	$-32M	$10M	$-25M	$-41M	$-68.0K	$-8M	$-14M
Stockholders' Equity	$-71M	$-109M	$20M	$298M	$360M	$303M	$232M	$505M	$0
Liabilities + Equity	$3.68B	$3.50B	$3.47B	$3.80B	$3.94B	$4.01B	$3.67B	$4.35B	$1.34B
Shares Outstanding	·	·	·	·	·	·	·	·	1,000

Nakit Akışı 12

AMRX için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Stock-based Comp	$32M	$28M	$27M	$32M	$28M	$21M	$22M	$168M	$0
Deferred Tax	$0	$0	$0	$0	$0	$0	$372M	$-9M	$742.0K
Amort. of Intangibles	$166M	$174M	$163M	$172M	$173M	$175M	$144M	$144M	$73M
Restructuring	$4M	$2M	$2M	$1M	$2M	$2M	$34M	$56M	$0
Operating Cash Flow	$340M	$295M	$346M	$65M	$242M	$379M	$2M	$250M	$234M
CapEx	$70M	$52M	$43M	$46M	$48M	$56M	$47M	$83M	$95M
Investing Cash Flow	$-112M	$-63M	$-69M	$-174M	$-194M	$-318M	$-20M	$-396M	$-99M
Dividends Paid	·	·	·	·	·	$0	$0	$183M	$375M
Financing Cash Flow	$-32M	$-212M	$-213M	$-107M	$-138M	$132M	$-46M	$288M	$-95M
Net Change in Cash	$195M	$19M	$64M	$-222M	$-90M	$194M	$-66M	$141M	$40M
Taxes Paid	$21M	$15M	$2M	$13M	$-16M	$100M	$10M	$35M	$-6M
Free Cash Flow	$270M	$243M	$302M	$19M	$194M	$323M	$-45M	$167M	·

Kârlılık 8

AMRX için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	36.9%	36.5%	34.3%	35.5%	36.7%	31.5%	21.7%	43.1%	·
Operating Margin	13.1%	8.9%	8.5%	-4.3%	7.3%	4.6%	-15.3%	-1.2%	·
Net Margin	2.4%	-2.6%	-3.3%	-12.2%	0.63%	4.6%	-22.2%	-1.2%	·
Pretax Margin	4.6%	-2.0%	-1.7%	-11.2%	1.5%	-1.8%	-13.5%	-12.2%	·
EBITDA Margin	13.1%	8.9%	8.5%	-4.3%	7.3%	4.6%	-15.3%	-1.2%	·
ROA	2.0%	-2.1%	-2.2%	-7.0%	0.33%	2.4%	-9.0%	-0.69%	·
ROE	-80.0%	165.1%	-49.8%	-82.2%	4.0%	34.0%	-98.2%	-7.8%	·
ROIC	14.5%	14.7%	10.1%	-3.3%	3.2%	-5.7%	-23.8%	-0.62%	·

Likidite ve Solventlik 4

AMRX için Yıllık Likidite ve Solventlik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	2.2	1.4	1.6	1.9	2.2	2.3	2.2	2.3	·
Quick Ratio	0.3	0.1	0.1	1.0	1.3	1.4	1.4	1.3	·
Debt / Equity	-36.3	-21.8	122.3	8.8	7.5	9.2	11.3	5.3	·
LT Debt / Equity	-36.2	-19.8	120.6	8.7	7.4	9.0	11.2	5.2	·

Verimlilik 3

AMRX için Yıllık Verimlilik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.8	0.8	0.7	0.6	0.5	0.5	0.4	0.6	·
Inventory Turnover	3.1	3.0	2.8	2.8	2.7	3.1	2.7	2.6	·
Receivables Turnover	·	·	·	3.2	3.2	3.2	3.0	4.0	·

Hisse Başına 3

AMRX için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue / Share	$9.29	$9.04	$13.59	$14.66	$13.79	$13.38	·	·	·
Cash Flow / Share	$1.05	$0.96	$1.96	$0.43	$1.59	$2.55	·	·	·
EPS (TTM)	$0.22	$-0.38	$-0.48	$-0.86	$0.07	$0.61	$-2.74	$-0.16	·

Büyüme Oranları 7

AMRX için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	8.1%	16.7%	8.2%	5.7%	5.1%	·	·	·	·
Revenue CAGR 3Y	10.9%	10.1%	6.3%	·	·	·	·	·	·
Revenue CAGR 5Y	8.7%	·	·	·	·	·	·	·	·
EPS YoY	·	·	·	·	-88.5%	·	·	·	·
EPS CAGR 5Y	-18.4%	·	·	·	·	·	·	·	·
Net Income YoY	·	·	·	·	-80.6%	·	·	·	·
Net Income CAGR 5Y	1.2%	·	·	·	·	·	·	·	·

Değerleme (TTM) 6

AMRX için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$3.02B	$2.79B	$2.39B	$2.21B	$2.09B	$1.99B	$1.63B	$1.66B	·
Net Income TTM	$72M	$-117M	$-84M	$-255M	$13M	$68M	$-604M	$-20M	·
P/E	57.3	-20.8	-12.6	-2.3	68.4	7.5	-1.8	-84.6	·
Earnings Yield	1.8%	-4.8%	-7.9%	-43.2%	1.5%	13.4%	-56.9%	-1.2%	·
Payout Ratio	·	·	·	·	·	0.00%	0.00%	-926.8%	·
Annual Payout	·	·	·	·	·	$0	$0	$183M	·

Gelir Tablosu 15

AMRX için Çeyreklik Gelir Tablosu verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$723M	$814M	$785M	$725M	$695M	$731M	$702M	$702M	$659M	$617M	$620M	$599M	$558M	$610M	$546M	$559M
Cost of Revenue	$402M	$517M	$511M	$438M	$440M	$468M	$433M	$452M	$421M	$427M	$388M	$379M	$379M	$394M	$351M	$359M
Gross Profit	$320M	$297M	$274M	$286M	$256M	$263M	$270M	$250M	$238M	$190M	$233M	$220M	$178M	$215M	$194M	$201M
R&D Expense	$38M	$35M	$63M	$48M	$40M	$54M	$61M	$36M	$39M	$46M	$41M	$38M	$39M	$42M	$50M	$51M
SG&A Expense	$139M	$146M	$138M	$124M	$118M	$129M	$119M	$116M	$113M	$109M	$113M	$106M	$102M	$102M	$100M	$99M
Operating Income	$142M	$112M	$70M	$111M	$100M	$76M	$89M	$95M	$-11M	$14M	$76M	$80M	$34M	$36M	$44M	$-199M
Other Non-op	$742.0K	$13M	$1M	$2M	$518.0K	$2M	$1M	$4M	$4M	$2M	$2M	$417.0K	$4M	$4M	$6M	$7M
Pretax Income	$80M	$55M	$-5M	$52M	$37M	$-15M	$15M	$20M	$-76M	$-83M	$23M	$30M	$-9M	$-8M	$2M	$-233M
Income Tax	$2M	$6M	$-23M	$16M	$13M	$5M	$4M	$4M	$6M	$10M	$-2M	$-23.0K	$668.0K	$-2M	$5M	$7M
Net Income	$62M	$35M	$2M	$22M	$12M	$-31M	$-156.0K	$6M	$-92M	$-99M	$10M	$12M	$-7M	$4M	$-8M	$-242M
EPS (Basic)	$0.20	$0.11	$0.01	$0.07	$0.04	$-0.10	$0.00	$0.02	$-0.30	$-0.57	$0.06	$0.08	$-0.05	$-0.03	$-0.02	$-0.80
EPS (Diluted)	$0.19	$0.10	$0.01	$0.07	$0.04	$-0.10	$0.00	$0.02	$-0.30	$-0.57	$0.06	$0.08	$-0.05	$-0.03	$-0.02	$-0.80
Shares (Basic)	316,023,000	-625,594,000	314,168,000	313,739,000	311,054,000	-617,065,000	309,647,000	309,117,000	307,279,000	-283,930,000	154,219,000	153,738,000	152,109,000	-301,334,000	151,393,000	150,993,000
Shares (Diluted)	328,933,000	-646,273,000	324,754,000	322,363,000	323,961,000	-626,905,000	309,647,000	318,957,000	307,279,000	-290,551,000	159,691,000	154,887,000	152,109,000	-301,334,000	151,393,000	150,993,000
EBITDA	$142M	·	$70M	$111M	$100M	·	$89M	$95M	$-11M	·	$76M	$80M	$34M	·	$44M	$-199M

Bilanço 22

AMRX için Çeyreklik Bilanço verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$198M	$282M	$201M	$72M	$59M	$111M	$74M	$44M	$47M	$92M	$87M	$109M	$145M	$26M	$87M	$92M
Receivables	·	·	·	·	·	·	·	·	·	·	·	·	$546M	·	$629M	$689M
Inventory	$642M	$606M	$614M	$609M	$601M	$612M	$596M	$576M	$571M	·	$576M	$551M	$529M	·	$544M	$533M
Prepaid Expense	$103M	$98M	$102M	$85M	$89M	$81M	$82M	$82M	$87M	·	$91M	$82M	$81M	·	$150M	$232M
Current Assets	$1.80B	$1.91B	$1.84B	$1.58B	$1.51B	$1.59B	$1.51B	$1.49B	$1.38B	·	$1.46B	$1.42B	$1.31B	·	$1.42B	$1.55B
PP&E (Net)	$445M	$443M	$435M	$440M	$427M	$425M	$431M	$425M	$440M	·	$452M	$459M	$463M	·	$470M	$484M
PP&E (Gross)	·	$1.05B	·	·	·	$988M	·	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	$606M	·	·	·	$564M	·	·	·	·	·	·	·	·	·	·
Goodwill	$594M	$595M	$596M	$597M	$597M	$597M	$598M	$599M	$599M	$599M	$599M	$599M	$599M	$599M	$600M	$601M
Intangibles	$535M	$563M	$588M	$650M	$689M	$732M	$780M	$820M	$859M	·	$983M	$1.02B	$1.06B	·	$1.16B	$1.20B
Other Non-current Assets	$55M	$58M	$39M	$45M	$45M	$60M	$36M	$77M	$74M	·	$89M	$93M	$86M	·	$108M	$80M
Total Assets	$3.54B	$3.68B	$3.60B	$3.42B	$3.37B	$3.50B	$3.46B	$3.51B	$3.46B	·	$3.69B	$3.70B	$3.63B	·	$3.87B	$4.04B
Accounts Payable	·	·	$266M	$206M	$193M	·	$235M	$200M	$175M	·	$177M	$140M	$137M	·	$531M	$562M
Current Liabilities	$728M	$882M	$862M	$1.11B	$1.08B	$1.13B	$1.10B	$1.11B	$834M	·	$761M	$777M	$704M	·	$818M	$993M
Other Non-current Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	$41M	·	$78M	$79M
Long-term Debt	$2.57B	$2.57B	$2.57B	$2.18B	$2.19B	$2.39B	$2.39B	$2.40B	$2.41B	·	$2.57B	$2.58B	$2.59B	·	$2.64B	$2.65B
Total Debt	$2.57B	·	$2.57B	$2.18B	$2.19B	·	$2.39B	$2.40B	$2.41B	·	$2.57B	$2.58B	$2.59B	·	$2.64B	$2.65B
Paid-in Capital	$536M	$572M	$563M	$555M	$546M	$560M	$553M	$546M	$539M	·	$715M	$708M	$701M	·	$684M	$676M
Retained Earnings	$-473M	$-535M	$-570M	$-572M	$-595M	$-607M	$-576M	$-576M	$-582M	·	$-392M	$-401M	$-413M	·	$-402M	$-399M
AOCI	$-112M	$-111M	$-106M	$-97M	$-86M	$-66M	$-74M	$-30M	$-24M	·	$4M	$8M	$4M	·	$13M	$868.0K
Stockholders' Equity	$-45M	$-71M	$-109M	$-112M	$-132M	$-109M	$-93M	$-57M	$-64M	·	$331M	$318M	$294M	·	$297M	$280M
Liabilities + Equity	$3.54B	$3.68B	$3.60B	$3.42B	$3.37B	$3.50B	$3.46B	$3.51B	$3.46B	·	$3.69B	$3.70B	$3.63B	·	$3.87B	$4.04B

Nakit Akışı 10

AMRX için Çeyreklik Nakit Akışı verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Stock-based Comp	$9M	$8M	$8M	$8M	$7M	$7M	$7M	$7M	$7M	$6M	$7M	$7M	$8M	$8M	$8M	$8M
Amort. of Intangibles	$30M	$36M	$40M	$46M	$45M	$50M	$43M	$40M	$40M	$41M	$41M	$41M	$41M	$45M	$44M	$42M
Restructuring	$650.0K	$2M	$143.0K	$1M	$571.0K	$493.0K	$172.0K	$220.0K	$1M	$114.0K	$1M	$82.0K	$510.0K	$109.0K	$581.0K	$0
Operating Cash Flow	$-27M	$130M	$118M	$84M	$7M	$118M	$142M	$40M	$-4M	$136M	$81M	$-11M	$140M	$-23M	$94M	$-126M
CapEx	$8M	$22M	$12M	$23M	$13M	$15M	$17M	$11M	$9M	$10M	$12M	$12M	$10M	$11M	$19M	$5M
Investing Cash Flow	$-22M	$-45M	$-22M	$-27M	$-18M	$-16M	$-21M	$-6M	$-20M	$-32M	$-13M	$-12M	$-12M	$-11M	$-49M	$-16M
Financing Cash Flow	$-59M	$-10M	$59M	$-42M	$-39M	$-61M	$-92M	$-35M	$-23M	$-101M	$-87M	$-12M	$-13M	$-22M	$-46M	$23M
Net Change in Cash	$-109M	$75M	$155M	$15M	$-50M	$40M	$29M	$-2M	$-47M	$4M	$-19M	$-36M	$116M	$-61M	$-2M	$-118M
Taxes Paid	$2M	$4M	$5M	$9M	$-4M	$6M	$-1M	$15M	$5M	$2M	$-3M	$496.0K	$3M	$23M	$-3M	$-11M
Free Cash Flow	$-35M	·	·	·	$-6M	·	·	·	$-14M	·	·	·	$130M	·	·	·

Kârlılık 8

AMRX için Çeyreklik Kârlılık verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Gross Margin	44.3%	·	34.9%	39.5%	36.8%	·	38.4%	35.6%	36.1%	·	37.5%	36.7%	32.0%	·	35.6%	35.9%
Operating Margin	19.6%	·	9.0%	15.4%	14.4%	·	12.6%	13.6%	-1.6%	·	12.2%	13.4%	6.2%	·	8.1%	-35.5%
Net Margin	8.6%	·	0.30%	3.1%	1.8%	·	-0.02%	0.85%	-13.9%	·	2.5%	3.7%	-2.8%	·	-1.4%	-43.3%
Pretax Margin	11.1%	·	-0.67%	7.1%	5.4%	·	2.2%	2.9%	-11.5%	·	3.7%	5.0%	-1.7%	·	0.40%	-41.6%
EBITDA Margin	19.6%	·	9.0%	15.4%	14.4%	·	12.6%	13.6%	-1.6%	·	12.2%	13.4%	6.2%	·	8.1%	-35.5%
ROA	1.8%	·	0.07%	0.65%	0.36%	·	0.00%	0.17%	-2.6%	·	0.41%	0.57%	-0.42%	·	-0.19%	-6.0%
ROE	-70.3%	·	-2.3%	-26.4%	-12.5%	·	-0.13%	4.6%	-79.5%	·	5.0%	7.4%	-4.6%	·	-2.4%	-77.3%
ROIC	5.5%	·	-9.9%	3.7%	3.2%	·	2.9%	3.4%	-0.50%	·	2.8%	2.8%	1.3%	·	-1.7%	-7.0%

Likidite ve Solventlik 4

AMRX için Çeyreklik Likidite ve Solventlik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	2.5	·	2.1	1.4	1.4	·	1.4	1.3	1.7	·	1.9	1.8	1.9	·	1.7	1.6
Quick Ratio	0.3	·	0.2	0.1	0.1	·	0.1	0.0	0.1	·	0.1	0.1	1.0	·	0.9	0.8
Debt / Equity	-56.6	·	-23.5	-19.4	-16.6	·	-25.6	-41.8	-37.8	·	7.8	8.1	8.8	·	8.9	9.5
LT Debt / Equity	-56.5	·	-23.4	-19.1	-16.4	·	-23.2	-37.9	-37.3	·	7.7	8.0	8.7	·	8.8	9.4

Verimlilik 3

AMRX için Çeyreklik Verimlilik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.1	·	0.1	0.1
Inventory Turnover	0.6	·	0.8	0.7	0.8	·	0.7	0.8	0.8	·	0.7	0.7	0.7	·	0.7	0.7
Receivables Turnover	·	·	·	·	·	·	·	·	·	·	·	·	1.0	·	0.9	0.8

Hisse Başına 3

AMRX için Çeyreklik Hisse Başına verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue / Share	$2.20	·	$2.42	$2.25	$2.15	·	$2.27	$2.20	$2.15	·	$3.88	$3.87	$3.67	·	$3.60	$3.70
Cash Flow / Share	$-0.08	·	·	·	$0.02	·	·	·	$-0.01	·	·	·	$0.92	·	·	·
EPS (TTM)	$0.31	·	$0.12	$0.13	$-0.24	·	$-0.22	$-0.14	$-0.21	·	$0.07	$-0.79	$-0.88	·	$-0.86	$-0.74

Değerleme (TTM) 4

AMRX için Çeyreklik Değerleme (TTM) verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$2.93B	·	$2.91B	$2.82B	$2.76B	·	$2.68B	$2.58B	$2.44B	·	$2.32B	$2.26B	$2.16B	·	$2.13B	$2.12B
Net Income TTM	$99M	·	$37M	$40M	$-74M	·	$-76M	$-64M	$-77M	·	$7M	$-245M	$-266M	·	$-266M	$-229M
P/E	40.1	·	83.4	62.2	-34.9	·	-37.8	-45.4	-28.9	·	60.3	-3.9	-1.6	·	-2.3	-4.3
Earnings Yield	2.5%	·	1.2%	1.6%	-2.9%	·	-2.6%	-2.2%	-3.5%	·	1.7%	-25.5%	-63.3%	·	-42.6%	-23.3%

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$3.02B	$2.79B	$2.39B	$2.21B	$2.09B
Brüt Kâr Marjı %	36.9%	36.5%	34.3%	35.5%	36.7%
Faaliyet Kâr Marjı %	13.1%	8.9%	8.5%	-4.3%	7.3%
Net Gelir	$72M	$-117M	$-84M	$-255M	$13M
Seyreltilmiş Hisse Başı Kâr	$0.22	$-0.38	$-0.48	$-0.86	$0.07

Bilanço

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Borç / Öz Sermaye	-36.3	-21.8	122.3	8.8	7.5
Cari Oran	2.2	1.4	1.6	1.9	2.2
Cari Oran	0.3	0.1	0.1	1.0	1.3

Nakit Akışı

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$270M	$243M	$302M	$19M	$194M

Son Haberler Bu şirketten bahseden son manşetler

Jenerik İlaçlara Odaklanan Amneal Pharmaceuticals Geliri 800 Milyon Doları Aştı - Amneal Pharmaceuticals ( NASDAQ : AMRX ) www.benzinga.com · 2 ay, 3 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

AMRX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

AMRX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

AMRX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Son Haberler Bu şirketten bahseden son manşetler

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar